Taken together, we disclosed the different immune characterization in two major and five rare DC subtypes, and revealed the unique profiles of four immune clusters, providing the potential managements of CD248 in the Cold tumor cluster and CD276/CAR-T in the Hot tumor cluster. This evidence concerns the gene CD248 and neoplasm.